Growth Metrics

Omeros (OMER) Free Cash Flow Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 24.91%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 20.11%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 14.71%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -10.65%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 31.42%
10 Omeros 772.03 Mn 636.71 Mn 9.31 Mn -27.71%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -27.71%
Dec 31, 2025 -16.20%
Sep 30, 2025 11.28%
Jun 30, 2025 -4.11%
Mar 31, 2025 -33.17%
Dec 31, 2024 -16.62%
Sep 30, 2024 -10.50%
Jun 30, 2024 -18.50%
Mar 31, 2024 -1.28%
Dec 31, 2023 -23.82%
Sep 30, 2023 2.27%
Jun 30, 2023 4.75%
Mar 31, 2023 175.70%
Dec 31, 2022 -3.31%
Sep 30, 2022 -51.78%
Jun 30, 2022 -5.28%
Mar 31, 2022 -4.98%
Dec 31, 2021 9.59%
Sep 30, 2021 13.69%
Jun 30, 2021 3.82%
Mar 31, 2021 -51.94%
Dec 31, 2020 -64.01%
Sep 30, 2020 -46.10%
Jun 30, 2020 -64.99%
Mar 31, 2020 10.34%
Dec 31, 2019 -28.28%
Sep 30, 2019 12.44%
Jun 30, 2019 -9.16%
Mar 31, 2019 7.57%
Dec 31, 2018 -14.12%
Sep 30, 2018 -36.10%
Jun 30, 2018 -23.15%
Mar 31, 2018 13.07%
Dec 31, 2017 35.72%
Sep 30, 2017 11.05%
Jun 30, 2017 18.05%
Mar 31, 2017 -4.65%
Dec 31, 2016 -210.92%
Sep 30, 2016 -0.53%
Jun 30, 2016 -10.95%
Mar 31, 2016 -22.45%
Dec 31, 2015 -8.08%
Sep 30, 2015 -25.09%
Jun 30, 2015 -23.08%
Mar 31, 2015 -46.33%
Dec 31, 2014 -28.50%
Sep 30, 2014 -57.10%
Jun 30, 2014 -30.72%
Mar 31, 2014 -9.21%
Dec 31, 2013 -27.14%
Sep 30, 2013 -22.36%